<DOC>
	<DOCNO>NCT03014609</DOCNO>
	<brief_summary>The principal objective study measure parameter inflammation , oxidative stress , vascular , respiratory , peripheral muscle function parameter , identify parameter indicative evolve cardiovascular risk ( CVR ) COPD patient , use multivariate analysis .</brief_summary>
	<brief_title>Cardiovascular Risk Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Reduced lung function major risk factor cardiovascular mortality ( CV ) , regardless age , sex history smoking . Similarly , CV event know cause mortality patient chronic obstructive pulmonary disease ( COPD ) . The investigator propose determine parameter influence evolution CV risk cohort COPD patient follow 5 year . For investigator study role inflammation , oxidative stress , vascular , respiratory peripheral muscle function parameter . In order study sufficient number patient investigator propose group data two cohort : first cohort 121 COPD patient already exist ( currently close inclusion still undergo follow-up ( NCT00404430 ) ) new cohort 150 , decompensated , COPD patient . This study major scientific interest enable obtain extremely important information well understand COPD .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>For patient stable COPD : Men woman age 18 85 FEV1/FVC &lt; 70 % proven BPCO Patients give free informed consent write For patient decompensated COPD : Men woman age 18 85 FEV1/FVC &lt; 70 % proven BPCO At time acute respiratory failure ( ARF ) , admit hospital : Respiratory rate &gt; 25 cycle per minute PaCO2 &gt; 45 mmHg blood pH &lt; 7.35 When include study : pH &gt; 7.33 end ARF , 2 day row , 3 7 day postD1 decompensation ( admission hospital ) Fever &lt; 38.5Â°C Patients give free informed consent write Obvious evolve infection CRP &gt; 100 mg/L Cardiac decompensation consider main cause decompensation chronic heart failure LVEF &lt; 45 % Evolving neoplasia On antioxidant : Nacetylcysteine , selenium , vit . C , vit . E Pregnant nursing woman Patients tutorship curatorship Patients participate drug clinical research study Patients affiliate French social security system ( equivalent ) Patients deprive liberty hospitalize without consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>inflammation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>peripheral muscle function</keyword>
</DOC>